ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP received a stock award from BIORA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/19/2023ACC: 0000899243-23-019263
→
10% Owner
Since Jun 2020
-16.73M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
33.27M acquired · 50M disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+9.24M
Price / share
—
Trade value
—
% of position
545.0%
9/18/2023
1.69M→10.93M
Total
Net shares
+9.24M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/18/2023 | A · Award | +9.24M | — | — | 545.0% | 1.69M | 10.93M |
| Total | +9.24M | $0.00 | ||||||
Derivative Transactions3
7.25% Convertible Senior Notes due 2025
Indirect
Converts to
Common Stock
556.02K shares
Shares
−50M
Strike price
89.9248
Held after
53.50M
Exercisable
—
9/18/2023
Warrant
Indirect
Converts to
Common Stock
7.40M shares
Shares
+7.40M
Strike price
0.001
Held after
7.40M
Exercisable
—
9/18/2023
Warrant
Indirect
Converts to
Common Stock
16.63M shares
Shares
+16.63M
Strike price
3.01
Held after
16.63M
Exercisable
—
9/18/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| 7.25% Convertible Senior Notes due 2025 Indirect | Common Stock556.02K shares | 9/18/2023 | D · Disposition | −50M | 89.9248 | — | 53.50M |
| Warrant Indirect | Common Stock7.40M shares | 9/18/2023 | A · Award | +7.40M | 0.001 | — | 7.40M |
| Warrant Indirect | Common Stock16.63M shares | 9/18/2023 | A · Award | +16.63M | 3.01 | — | 16.63M |